SHAREHOLDER ALERT: Weiss Law Investigates AVEO Pharmaceuticals, Inc.

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AVEO Pharmaceuticals, Inc. ("AVEO" or the "Company") (NASDAQ: AVEO), in connection with the proposed acquisition of the Company by LG Chem, Ltd. Under the terms of the merger agreement, the Company's shareholders will receive $15.00 in cash for each share of AVEO common stock owned. The transaction is valued at approximately $566 million. 

Read more at prnewswire.com